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                                                      ABSTRACT
“A STUDY TO DETERMINE THE PREVALENCE OF PRIMARY OPEN
ANGLE GLAUCOMA IN PATIENTS WITH SYSTEMIC HYPERTENSION"
Key Words Primary Open Angle Glaucoma, Intraocular Pressure, Systemic
Hypertension
OBJECTIVES OF THE STUDY:
                           The aim of the study was to find the prevalence of primary
open angle glaucoma in patients with systemic hypertension presenting to
Stanley OPD to find the association of systemic hypertension with the
occurrence of POAG.
METHODS:
                        In this cross-sectional case control study, 100 patients with
systemic hypertension and 100 non hypertensive subjects were evaluated
at department of ophthalmology at Stanley medical college for the presence of
primary open angle glaucoma based on predetermined criteria and the
prevalence of primary open angle glaucoma in both the groups was found and
analysed to find the asscociation of primary open angle glaucoma and systemic
hypertension.
RESULTS:
Systemic hypertension was not found to have a statistically significant
association with the occurrence of  primary open angle glaucoma{ odds ratio
1.936 with 95% confidence interval being from 0.687 to 5.457. The mean
intraocular pressure of hypertensive group was mildly higher than the mean
intraocular pressure non hypertensive group  and the difference in the mean IOP
of both the groups was statistically significant { P value – 0.006}.  The
occurrence of POAG was more in patients with systemic hypertension for a
longer duration i.e  55.5%   of persons with POAG in this group was diagnosed
with hypertension for ? 10 years. The prevalence of POAG also increased with
increasing age in both the groups with 66.6% of subjects being above 60 years
of age.
Conclusion:
                  In our study systemic hypertension was not found to have a
statistically significant association with POAG,but persons with long duration
of hypertension and advancing age, need to be monitored for high IOP and optic
nerve head changes to aid in early diagnosis and also to minimize visual
morbidity and blindness due to glaucoma.
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INTRODUCTION
           Glaucoma is a potentially blinding disease affecting a large number of
people worldwide. It is a frequent cause of permanent blindness in the world.
           Glaucoma is a progressive optic neuropathy characterised by
recognizable patterns of alterations in the structure of the optic nerve head and
nerve fiber layer of the retina and consequent visual field defects6. Glaucoma
can be subdivided into primary glaucoma in which the mechanism for the
disease is unknown and secondary if the glaucoma is secondary to another
ocular or systemic disease.
            Among all types of glaucoma, primary open angle glaucoma is said to
the most frequent one. Asians tend to have higher rates of angle closure
glaucoma. This may be true, or, in some instances, might be an artefact because
angle closure glaucoma may cause acute symptoms, therefore, it is more readily
diagnosed but POAG is relatively asymptomatic till late stages and they readily
go undiagnosed.
        POAG is often asymptomatic & patients may suffer substantial vision loss
prior to diagnosis and treatment7. Therefore it is essential to identify at-risk
populations & develop accurate screening tests to make the diagnosis so that
sight-preserving treatment can begin early in the disease process. Several
population based studies have been carried out to determine the prevalence of
POAG and to identify risk factors for the disease. Age8,9,10, race12, myopia17,
systemic HT11,15, diabetes11,13,14, family history18 etc have long been considered
as risks for occurrence of primary open angle glaucoma  but  recent studies have
questioned the strength of these associations.
         Blood pressure increases with age in most populations but the relationship
between systemic hypertension and POAG is yet to be successfully elucidated.
Several large-scale studies have yielded dissimilar & even contradictory results.
Systemic HT causes direct microvascular damage and can impair blood flow to
the optic nerve, precipitating POAG. Significant ethnic & racial variation exists
in the prevalence and complications of HT. Evaluation of hypertension as a risk
factor for POAG in our population is essential so that the disease can be
detected at an early stage by screening these high risk groups.
REVIEW OF LITERATURE
HISTORIC REVIEW:
       Glaucoma has been known since Roman era. The word "glaucoma" was
first described in Hippocrates' Aphorisms about  400  BC  as  an  ailment  of  old
men.!
In Hippocratic writings,’ glaucosis’  derived from the Greek word
glaucos, meaning glaze , later more specified as a greenish glaze of the lens.
 In 1626 Dr.Banister first established the concept of elevated intra-ocular
pressure in glaucoma.
Impairment of the aqueous drainage of the eye as the cause of glaucoma
was described by Hermann Boerhave in 1708.Inflammation as a cause of
glaucoma was put forth in 1722 by Charles Saint.
Emphasis was put on the intraocular pressure in the diagnosis of
glaucoma till the introduction of ophthalmoscope in 1853 following which optic
disc changes in glaucoma was recognised.
In 1862, Donder published his classical paper in which he described
‘Glaucoma simplex’ as a disorder with increasing tension of the eye, excavation
of the disc, shift of the vessels in the disc, loss of visual field and loss of vision.
Today glaucoma is defined as a disease causing progressive atrophy of
the optic nerve with loss of ganglion cells and their axons along with specific
visual field defects.
ANATOMY
             Aqueous humor is produced in ciliary body and drained via anterior
chamber angle. These two structures play an important role in maintaining
aqueous humour dynamics and also intraocular pressure.
CILIARY BODY
In the eye uveal tract is composed of iris,ciliary body and choroid. Ciliary
body is seen between iris and choroid and is attached with sclera spur anteriorly.
Histologically it is composed of epithelium, vascular structures and ciliary body
muscle.
PARTS OF THE CILIARY BODY
?? Pars plicata:
 Pars plicata contains the ciliary processes which are the site of aqueous
production, they are nothing but ridges which are radially oriented and
projecting into the posterior chamber. Pars plicata forms anterior one third of
ciliary body.
?? Pars plana:
Pars plana is smooth, devoid of ridges and forms the posterior two third
of ciliary body.
HISTOLOGY OF CILIARY PROCESS
Ciliary process is made up of  a core of connective tissue substance with
numerous capillaries and a overlying epithelium. Capillary network in ciliary
processes are fenestrated.
           Epithelium of ciliary process is double layered with an inner layer of
non pigmented epithelium and outer layer of pigmented epithelium lying
adjacent to the stroma.  Blood aqueous barrier is formed by the tight junctions
between the cells of the non pigmented epithelium.
 ANGLE OF ANTERIOR CHAMBER
 Schwalbe’s line, trabecular meshwork, canal of Schlemn and the scleral
spur are the main structures forming the anterior chamber angle.
SCHWALBE’S LINE
The anteriormost structure of the anterior chamber angle is the
Schwalbe’s line and it is the point where descemet’s membrane ends , it also
marks the point where corneal endothelium continues as trabecular
endothelium.
TRABECULAR MESHWORK
 The trabecular meshwork is an important structure of the anterior
chamber angle playing a vital role in the maintainence of IOP, it is triangular in
outline with its apex directed towards Schwalbe’s line and base towards sclera
spur.
PARTS OF TRABECULAR MESHWORK
? Uveal meshwork
? Corneoscleral meshwork
?Juxta-canalicular meshwork
The inner layers of trabecular meshwork is formed by uveal meshwork,
the next layer is formed by corneoscleral meshwork and it extends from anterior
part of sclera sulcus to sclera spur.
           Juxtacanalicular meshwork is considered as the main site of resistance for
aqueous outflow and it is made up of  proteoglycan matrix with embedded
collagen and endothelial cells connected by gap junctions.
SCHLEMN’S CANAL
Schlemn’s canal is a vascular channel lying within the sclera sulcus. It
consists of two layer of endothelial cells. The outer layer is attached to sclera.
The inner wall plays an important role in IOP maintenance by its invaginations
called ‘ giant vacuoles’6,7. These giant vacuoles increase in size and number
when IOP increases facilitating aqueous outflow thus reducing IOP.
Schlemn’s canal also contains collector channels which drain aqueous
into the aqueous veins which in turn drain into episceral and conjunctival veins.
These collector channels are of three types namely direct (4-6) which connects
directly with aqueous veins, indirect type (15-20) which forms an intrascleral
plexus and then drain into aqueous veins and an intermediate type (4-6)
SCLERAL SPUR
The scleral spur is nothing but a wedge shaped projection from the
anterior sclera and attaching itself anteriorly onto the trabecular meshwork.
Posteriorly is attached to sclera and longitudinal ciliary muscle fibres.
As sclera spur is attached posteriorly to ciliary muscle, when ciliary
muscle contracts it pulls the sclera spur posteriorly which in turn pulls the
trabecular lamellae attached to it. This results in widening of intertrabecular
spaces and also prevents the schlemn’s canal to get narrowed or collapsed, in
this way they help in aqueous humor outflow.
OUTFLOW OF AQUEOUS
CONVENTIONAL OUTFLOW
Outflow of aqueous from the anterior chamber angle through the
trabecular meshwork into the schlemn’s canal which in turn drains into the
episcleral veins via aqueous veins is considered as the conventional outflow
pathway and as it drains through the schlemn’s canal it is also termed the
canalicular pathway.
Contraction of the ciliary muscle through its insertion into the trabecular
meshwork increases pore size in the meshwork and hence the rate of aqueous
drainage. Passage of aqueous into Schlemn's canal depends on cyclic formation
of transcellular channels in the endothelial lining. The collector channels from
Schlemm's canal drain into the episcleral veins via aqueous veins which are
about twelve in number.
UVEOSCLERAL OUTFLOW
            It is estimated that up to 15% (much higher values suggested by recent
studies) of  aqueous outflow occurs via an alternative route  known as
UVEOSCLERAL OUTFLOW described in 1960s by Bill.
In this pathway aqueous enters the ciliary body course through the loose
connective tissue and then pass between ciliary muscle fibres to enter
supraciliary space, subsequently into suprachoroidal space. From here aqueous
is drained by the veins draining the uvea. But this pathway is not affected by
changes in IOP and remains the same both in high and low intraocular pressures
but outflow can be modified pharmacologically. Uveoscleral outflow is
decreased by pilocarpine and increased by drugs like adrenaline and
prostaglandin analogs.
GRADING OF ANGLE
              In an open angle structures seen from posterior to anterior are the root
of the iris,ciliary body, scleral spur, trabecular meshwork and  the Schwalbe’s
line.
Anterior chamber angle is graded by various systems namely,
           SHAFFER GRADING SYSTEM
          SCHEIE GRADING SYSTEM
SPAETH GRADING SYSTEM
SHAFFER’S GRADING SYSTEM
In Shaffer’s grading system anterior chamber angle is graded by taking
into account the angle formed between the  anterior iris surface and posterior
corneal wall.25
SHAFFER’S GRADING SYSTEM
Grade Angle Width Description
4 45-35 Wide open
3 35-20 Wide open
2 20 Narrow
1 10 Extremely narrow
S <10 Slit
0 O Closed
SPAETH GRADING SYSTEM
Spaeth grading of anterior chamber angle is based on three variables
a) Insertion of iris root
b) Angular width
c) Configuration of iris
Insertion of iris root
          A   - Anterior to Schwalbe’s line.
B   - Behind Schwalbe’s line.
C   - Centered at scleral spur
D   - Deep to scleral spur
E   - Extremely deep in ciliary body.
Configuration of iris
s    - ‘Steep’ or convexly configured
r    - ‘Regular’ or flat
q    - ‘Queer’ for deeply concave
SCHEIE GRADING SYSTEM
This system is based on the extent of angle structures visualized
All structures seen                       -Wide open
Iris root not seen                          - Grade I narrow
Ciliary body band not seen          - Grade II narrow
Posterior trabeculum obscured    - Grade III narrow
Only Schwalbe’s line visible       - Grade IV narrow
                       SCHEIE GRADING SYSTEM
GONIOSCOPY
            Gonioscopy refers to the technique used to view and define the
structures and abnormalities of anterior chamber angle or iridocorneal angle.
PRINCIPLE
As the light emitted from angle structures undergo total internal
reflection, it is not possible to visualise the angle through intact cornea.  Contact
lenses have an index of refraction  similar to that of the cornea, allowing light to
enter the lens and then be refracted (goniolens) or reflected (gonioprism)
beyond the contact lens-air interface. Gonioscopy can be done by two methods
i.e direct and indirect gonioscopy.
Direct gonioscopy:
 In this method,anterior curve of the contact lens i.e configuration of the
contact lens is such that exiting light rays strike the contact lens/air interface at a
steeper angle than critical angle so that they will pass directly to the observer
without reflection inside the lens e.g is koeppe lens.
Indirect gonioscopy :
 In indirect gonioscopy light rays from the angle are reflected by a mirror
such that they exit the lens at an angle much less than the critical angle. So the
angle viewed is the angle exactly opposite to the mirror. Indirect gonioscopy is
done with the help of a slit lamp. Examples are Goldmann and Zeiss types of
lenses.
t lamp angle grading s
AQUEOUS HUMOR:
Aqueous humor  flows from its production site( nonpigmented epithelium
of ciliary body) into the posterior chamber, then into the anterior chamber
passing between the posterior iris surface and lens .It exits from the anterior
chamber via trabecular and nontrabecular routes. The trabecular route is at the
angle of the anterior chamber flowing through the trabecular meshwork (TM) of
the sclera, into Schlemm's canal and then via its efferent channels,the aqueous is
carried to the episcleral vessels, where aqueous mixes with blood. A balance
between aqueous humor production and the resistance to its outflow is essential
to maintain a normal intraocular pressure.
AQUEOUS HUMOUR DYNAMICS
It is important to understand the aqueous humour dynamics for the
evaluation and management of glaucoma. Aqueous humour is formed in the
ciliary process by three important mechanisms namely simple diffusion,
ultrafiltration and active secretion. Active secretion of ions across the
epithelium of the ciliary body is considered as the primary mechanism for the
formation of aqueous these days. Active secretion creates an osmotic gradient
which in turn leads to passive flow of water into the posterior chamber. This
process is decreased by hypoxia, hypothermia and any inhibitor of active
metabolism.
 Aqueous humor exits the eye via two pathways. The trabecular
meshwork is considered the conventional, pressure-dependent pathway, while
the uveoscleral pathway is considered the unconventional, pressure-independent
pathway.
 Mean outflow facility is 0.22 to 0.33 microlitre/min/mmHg. Outflow
facility decreases with age, surgery, trauma, medications, endocrine factors etc.7
          Trabecular outflow accounts for 5 to 95% of aqueous drainage. This flow
is pressure dependent, meaning that the flow is proportional to the difference
between IOP and the hydrostatic pressure in the canal.
          In the uveoscleral outflow pathway, aqueous humor exits the eye through
the interstitial spaces between the ciliary muscle fibres into the supraciliary and
suprachoroidal space where it is absorbed into the venous system. There are
age-related changes to both the TM and the uveoscleral outflow pathways,
including decreased TM cellularity with age and increased extracellular
depositions in both the TM and uveoscleral pathways that are associated with
age-dependent decreased aqueous outflow.
INTRAOCULAR PRESSURE
 Although Intraocular Pressure is not part of the definition of glaucoma,
reduction of IOP remains the only proven and approved means of glaucoma
management and is the single most important modifiable risk factor. To cause
glaucomatous optic neuropathy, there is a complex interaction between IOP and
other risk factors. Therefore the study of those elements that contribute to the
production and drainage of aqueous humor, maintenance of intraocular pressure
and variation of intraocular pressure is material to understand the
pathophysiology of this disease.
DETERMINANTS OF INTRAOCULAR PRESSURE
 Intraocular pressure (IOP) is determined by three factors namely aqueous
formation (F), facility of outflow (C), and episcleral venous pressure (Pv) .
Goldmann equation relates these factors by the formula
Po= F/C + Pv ,
or if solving for F then
F = (Po - Pv) C
in which Po represents the  IOP in the undisturbed eye in mmHg, F represents
aqueous formation  in ul/min, C is aqueous outflow facility  in ul/min/mmHg
and Pv  stands for episcleral venous pressure  in mmHg.
From the equation, it is clear increase in IOP occurs when the aqueous
formation rate increases the episcleral venous pressure increases or the outflow
facility decreases.
NORMAL INTRAOCULAR PRESSURE:
The range of intraocular pressures in the normal population is fairly wide;
the average intraocular pressure is approximately 16 mmHg with a standard
deviation of 2.5. The ‘statistical’ normal range, defined as the mean two
standard deviations, would therefore be approximately 11–21 mmHg.
IOP is influenced by number of factors like age, sex, race, heredity,
obesity, posture, exercise etc. IOP is also altered by cholinergic and adrenergic
inputs Corticosteroids raise IOP; diabetes associated with increased IOP;
myopic individuals have higher IOP.
Diurnal variation -Most people have a diurnal pattern,  IOP varies with
an average of 3–6 mmHg in normal individuals.
TONOMETRY
 Intraocular pressure is measured clinically using tonometers. Tonometers
work on the principle that the pressure within the globe is directly related to the
force required to deform the same.
           Tonometers developed for the purpose of   measuring intraocular pressure
fall into two categories:
Indentation Tonometers – Here the amount of corneal or globe
deformation in response to an externally applied weight is determined.
Applanation tonometers – Here the force required to flatten a surface area
of cornea is determined.
          In both applanation and indendation tonometers, the factors that decide
the measured IOP includes the actual intraocular pressure, central corneal
thickness and corneal deformability.Applanation tonometer is considered as the
gold standard tool for IOP measurement.
 INDENTATION TONOMETERS
Shiotz in 1905 described the indendation tonometer. The Schiotz
tonometer is an indentation instrument which measures IOP by registering the
depth of indentation of the cornea produced when the instrument with a known
weight is applied to the  eye. The weight is carried on a plunger and when the
weight is applied to the eye, the intraocular pressure provides a
counterbalancing force which pushes back up on the plunger. This causes a
deflection of the pointer along the inclined scale. Each unit on the scale, which
ranges from 1 to 20, corresponds to an indentation of 1/20 of a mm in the
cornea. High intraocular pressure resists indentation, resulting in low scale
readings, while low intraocular pressure allows for easy indentation, manifested
by high scale readings. The intraocular pressure is determined by referring to
the calibration chart and reading the pressure that corresponds to the scale
reading for the plunger load applied.
Advantages:
Low cost
Portability
Disadvantages:
Ocular rigidity tends to influence the tonometry readings, example in
patients with low ocular rigidity like myopia it tends to give a falsely low IOP.
APPLANATION TONOMETERS
Applanation tonometers are of two types :
1. Variable area – Here force is kept constant by using a fixed weight and
the diameter of the area flattened is measured and this value gives an
estimate of IOP. The prototype of this principle is Maklakov tonometer.
2. Variable force - Here area applanated is kept constant and the force
required to applanate this fixed area determines the IOP. The prototype is
the Goldmann applanation tonometer, which was introduced in 1954.
Others include Perkins applanation tonometer, Mackay Marg tonometer,
Tonopen etc.
GOLDMANN APPLANATION TONOMETER
Goldmann applanation tonometry is still considered the gold standard
technique for measurement of IOP.
      In using the Goldmann applanation tonometer, the flattening force to the
cornea is supplied by a coiled spring contained in the instrument, controlled by
a rotating knob at the base, and is applied to the anesthetized eye by the tip of a
split prism device through which the cornea may be viewed with the slit lamp.
The area of cornea flattened is 3.06 mm in diameter. Topical anesthetic and
fluorescein are applied to the eye, and the tear film illuminated using the cobalt
blue filter of the slit lamp. As the instrument is applied to the eye, the
applanating head creates a circular tear film meniscus which may be viewed
through the slit lamp. The prism in the applanating head splits the circular
image into two semicircles, and the end point of the measurement is determined
by adjusting the knob until the inside edges of the semicircles are just touching.
The intraocular pressure is then determined by multiplying the reading on the
scale on the knob by ten.
Source of errors of applanation tonometry:
Corneas that are too thin or thick can cause errors in IOP measurement.
Astigmatism >3 diopters can give false values. Too much of flourescein
staining as well as inadequate staining can cause thick or thin mires and show
inaccurate intraocular  pressure.
Advantages:
Accurate method of intraocular pressure measurement
Accurate IOP measurement in patients with scleral rigidity.
Disadvantages:
Cannot be used in infants and children
Cannot be used in operative room
Goldmann tonometry  will not be  accurate if the cornea is very much
thinner or thicker than average, highly astigmatic, irregular, edematous or
scarred
NONCONTACT TONOMETERS
In non contact tonometers, cornea is not touched and flattened with a puff
of air  and the time required to flatten it is measured and correlated with IOP.
Ocular response analyser a type of non contact tonometer is gaining
popularisation in recent years.
Advantages:
No corneal trauma
No risk of infection
OPTIC NERVE HEAD ANATOMY AND BLOOD SUPPLY
Glaucoma is essentially an optic neuropathy and damage to the optic
nerve is occurs within the neural, cellular and connective tissues of the optic
nerve head. Knowledge about the anatomy of the normal optic nerve and the
pathological changes that occur in glaucomatous optic neuropathy (GON) is
essential for the early detection and monitoring of these diseases.
The optic nerve (cranial nerve II) is formed by the axons of the ganglion
cells of the retina; it then traverses the scleral canal to exit the eye. Optic nerve
ends at the level of optic chiasma where the axons of one side merge with axons
of the contralateral optic nerve.
From its origin in the eye until it reaches the optic chiasma in the anterior
cerebral fossa the ON can be divided into four segments
Intraocular part: 1 mm
Intraorbital part:  30 mm
Intracanalicular part: 6-9 mm
 Intracranial part: 10 mm
 The intraocular portion of the ON is also referred to as the optic nerve
head (ONH). The visible most anterior part of the ONH is known as the optic
disc.
Optic nerve head consists of the following zones:7
         Surface nerve fibre layer
         Prelaminar region
         Lamina cribrosa region
         Retrolaminar region
SURFACE NERVE FIBRE LAYER
           Anteriormost part of the optic nerve head is called as the surface nerve
fiber layer and it consists of approximately one million ganglion cell axons (also
known as nerve fibers) from all over the retina that converge onto this part and
exit through the scleral canal. Small branches from retinal arterioles and
cilioretinal arteries supply the superficial nerve fibre layer.
PRELAMINAR REGION
         Arterial branches from the peripapillary choroid and short posterior ciliary
arteries supply the pre-laminar region.
LAMINAR REGION
       The lamina cribrosa consists of a meshwork formed by interlinked
connective tissue plates (cribriform plates).Central retinal vessels and bundles
of axons pass through a series of round or oval apertures within the meshwork.
The 300–400 pores that transmit axon bundles show a considerable variation in
size, with the largest pores typically found in the superior and inferior
quadrants.  Banches of short posterior ciliary arteries either directly or its
branches from circle of Zinn –Haller supplies lamina cribrosa.
RETROLAMINAR REGION
             Axons within the post laminar optic nerve are myelinated, which
principally accounts for the doubling of the optic nerve diameter from 1.5mm at
the pre-laminar and laminar levels to 3.0 mm in the post-laminar region.
Retrolaminar part supplied by centrifugal branches from central retinal artery
and centripetal branches from pial vascular plexus.30
Venous drainage occurs via the central retinal vein and there may also be
some drainage into the peripapillary choroid
OPTIC NERVE HEAD FEATURES
Upon clinical examination the optic disc is generally described as
consisting of  Neuraretinal rim (the nerve axons)
         Optic cup(the central area of the disc surrounded by the
neural rim).
CUP DISC RATIO
The optic cup is relatively devoid of nerve fascicles and normally appears
as a round to oval depression of variable size, usually of a lighter color.
The diameter of the optic cup divided by the diameter of the optic disc is
known as the cup/disc ratio (C/D ratio) and is expressed in decimal notation
(0.1, 0.2, etc.).  Ninety per cent of normal individuals have an average C/D ratio
of less than 0.5 measured by direct ophthalmoscopy.
The size of the optic cup changes proportionally with the size of the optic
disc; a larger cup occurs in larger disc and vice versa. Assuming discs of equal
size, both optic cups usually appear fairly symmetric in normal individuals.
Only 1–2% has more than a 0.2 difference between the cups.
NEURORETINAL RIM
The neuroretinal rim is normally pink in colour.The rim is broadest in the
inferior disc, then the superior disc, then the nasal disc, and thinnest in the
temporal disc and it correlates with the morphology of the lamina cribrosa – the
largest pores and the least amount of interpore connective tissue are in the
inferior and superior poles, compared with the nasal and temporal sectors.
OPTIC NERVE HEAD IN GLAUCOMA
1.  Progressive enlargement and/or deepening of the cup (‘cupping’ is
the direct result of axonal loss and the resulting structural alterations in the
lamina cribrosa  ie backward bowing  lamina cribrosa)31
2. Neuroretinal rim is formed by the  extension of the superficial
nerve fiber layer into the optic disc and hence it is important to evaluate
neuroretinal rim. NRR changes in glaucoma are notching of the rim, NRR loss
and thinning in one or more quadrants, asymmetry of NRR between the two
eyes and haemorrhages crossing the rim.
OPTIC DISC CUPPING AND NRR THINNING
3. VASCULAR SIGNS
? “ Bayonneting,”  occurs when a vessel take a sharp 90° bend as it passes
through  an acquired pit formed as a consequence of  neuroretinal rim
loss and then emerges out from the edge of optic disc.
?  “Baring” of circumlinear vessels
? “Nasalization” of blood vessels – Normally blood vessels at the optic
nerve head emerge centrally, in glaucoma owing to diffuse neuroretinal
rim loss ,major  vessels  appear to emerge more nasally and this
appearance is named as nasalisation of major blood vessels.
?Splinter haemorrhages in the margin of ONH. These hemorrhages are
more common in eyes with norm al-tension glaucoma, usually indicating
progression of disease.
4. NERVE FIBRE LAYER DEFECTS
               Nerve fiber layer defects appear as a series of striations radiating in an
arcuate fashion from optic nerve head above and below macula and not crossing
the horizontal raphe.
Localized defects – These are wedge shaped areas occurring wider
peripherally radiating from the optic nerve head.
 Diffuse loss – Diffuse loss of nerve fiber layer is seen in advanced
glaucoma.
5. PERIPAPILLARY ATROPHY
Atrophy around the disc consists of two zones –
? Beta zone - Zone of chorioretinal atrophy immediately surrounding the
disc marked by significant atrophy of the retinal pigment epithelium and
choriocapillaris, with more clear visibility of the choroidal vessels and
sclera.
? Alpha zone -  alpha zone surrounds the beta zone and represents areas of
chorioretinal thinning occurring as irregular areas of hypo and
hyperpigmentation.
OPTIC NERVE HEAD ASSESSMENT
DIRECT OPHTHALMOSCOPY
 It is the most commonly used method for assessing the optic nerve head
by general ophthalmologists and  it provides a non stereo view of the optic
nerve head.
SLIT LAMP BIOMICROSCOPY
Optic nerve head can be assessed with a slit lamp biomicroscopy using
hand held high power convex lenses ( 78 D & 90 D) and fundus contact lenses
like Goldmann three mirror lens to provide a stereoscopic view of the disc
FUNDUS PHOTOGRAPHY
Fundus photography is the most widely used technology nowadays to
document the optic nerve head appearance objectively and also helps in
detecting the progression of the disease.
CONFOCAL SCANNING LASER OPHTHALMOSCOPY
 Confocal scanning laser ophthalmoscopy takes  transaxial laser scans (
around 64) through the optic nerve head and peripapillary retina to reconstruct a
high resolution  three dimensional imaging of optic nerve head    and nerve fiber
layer.
 Heidelberg Retinal Tomograph (HRT) is a prototype of  Confocal
scanning laser ophthalmoscopy.
Advantage – Rapid image acquisition time, reduced need for pupillary
dilation or clear media.
OPTICAL COHERENCE TOMOGRAPHY
 OCT uses low-coherence laser light (850 nm) and based on its property
of optical backscattering,it takes axial cross-section of tissues as it passes
through layers of different optical density. OCT assess optic nerve head using
this laser interferometry principle and quantifies the amount of nerve tissue in
optic nerve.
NERVE FIBER LAYER ANALYSIS
SCANNING LASER POLARIMETRY (GDxVCC)
 In Scanning laser polarimetry ,a laser beam is passed to the posterior
retina and  changes in the polarization of the reflected beam is measured and is
used to quantify  peripapillary RNFL .The software used in nerve fiber analyzer
is named as GDx. VCC  stands for variable corneal compensator which
accounts for the variable corneal birefringence.
OPTICAL COHERENCE TOMOGRAPHY
 Optical coherence tomography uses the reflected and backscattered light
to create reflected images of various retinal layers and is displayed as quadrants,
clockhours and overall mean as measured by computer analysis.
Fourier-domain OCT yields up to five times higher resolution with faster
imaging speed (60 times faster) than conventional time-domain OCT.
VISUAL FIELDS
Visual field testing gives a non-invasive direct measure of visual
function. The distribution and arrangement of the retinal nerve fibres govern the
pattern of visual field loss in glaucoma and scotomas follow the shape of these
nerve fibre bundles, giving rise to characteristic glaucomatous field defects
which may be absolute, or relative, or a combination of both.
GLAUCOMATOUS VISUAL FIELD DEFECTS
? Early visual loss within the arcuate area ( starts from blind spot and
arches above or below fixation), they most often appear as
localised defect or PARACENTRAL SCOTOMAS
? Early arcuate defect may connect with the blind spot giving rise to
SIEDEL SCOTOMA.
? The localised defect then coalesce filling the entire arcuate area
from blind spot forming ARCUATE OR BJERRUM SCOTOMA
? Further disease progression leads on to DOUBLE ARCUATE OR
RING SCOTOMA.
? Loss of nerve fibers rarely proceeds at the same rate in the upper
and lower portions of  the horizontal meridian creating a step like
defect along the horizontal raphe referred to as the NASAL STEP.
? Continued damage results in a temporal island and central island in
advanced glaucoma.33
? Temporal island is more resistant and may persists lond after
central vision is lost.
 PERIMETRY
 There are two main types of perimetry namely
1. Kinetic perimetry
2. Static perimetry
KINETIC PERIMETRY
             A stimulus of given size and brightness is selected and moved from
where it is not seen until its threshold is crossed. Island of vision is kinetically
explored along XY axis.  Eg – Goldmann kinetic perimetry.
STATIC PERIMETRY
         Automated static perimetry is the most reliable and sensitive means of
testing a visual field. Here relative differential light sensitivity throughout  the
field of vision is determined based on either age corrected normal data or
patients response to preliminary spot tests.
Testing Strategies:
1.Suprathreshold:
        In this strategy a stimulus that is slightly brighter than  the anticipated
normal for the corresponding retinal location is presented. It is mainly used in
screening of glaucoma.
2.Threshold:
         A staircase procedure is applied in which a retinal threshold is crossed by
increasing or decreasing stimulus and is then crossed second time with smaller
increments of change in luminosity.
Types of threshold testing :
1. Standard Full Threshold Testing
               The differential light sensitivity is determined at 76 locations
spread over a central 30 degrees at 6 degrees apart using staircase
phenomenon.Here the threshold is crossed twice , initially in 4dB
increments followed by 2 dB increments.
2.  Fastpac
       Threshold is estimated with single crossing in 3 dB in contrast to
standard double threshold crossing with 4dB and 2 dB, so as to reduce
time
3.  Swedish Interactive Threshold Algorithm (SITA)
             Swedish Interactive Threshold Algorithm (SITA)  uses standard 24-
2 or 30-2 patterns to  assess visual field based on the probability analysis of
patterns of glaucomatous damage .It reduces testing time to half  and is more
time efficient than standard full threshold strategy.
There are two versions off SITA currently available now namely
               SITA Standard
               SITA Fast
SITA standard and SITA Fast  are so fast that they take approximately half
the time to complete as compared to standard full threshold and  FASTPAC
algorithm respectively.
STANDARD ACHROMATIC PERIMETRY (SAP)
Also known as white on white perimetry , here white stimulus is
projected on white background. The target is presented randomly at
54 locations within the central 24 degree or 76 locations in central
30 degree.
SHORT WAVE AUTOMATED PERIMETRY(SWAP)
Short wave automated perimetry  uses blue wave length as stimulus and a
specific colour and brightness of yellow is used as back ground illumination.
The red and green cones are desensitised by yellow back ground. The 440nm
blue stimulus falls on blue cones.
          Blue yellow ganglion cells are selectively damaged in early glaucoma
hence early diagnosis is possible by SWAP by 3-5 years earlier than standard
achromatic perimetry.
FREQUENCY DOUBLING PERIMETRY
Frequency doubling perimetry is designed based upon a frequency
doubling illusion that occurs when viewing a grating with a low spatial
frequency and a high temporal rate. The target in frequency doubling perimetry
is a sinusoidal grating (0.25 cycles per degree )that subtends an angle of 10
degree. Early glaucomatous defect are detected early than standard perimetry
and has a advantage of shortest time,portability and reproducibility.
PRIMARY OPEN ANGLE GLAUCOMA
The mechanistic classification is probably the most common scheme for
sorting out the various glaucomatous diseases. The main division of this
classification is open-angle and angle closure glaucoma based on gonioscopic
findings. The other important differentiation in this classification scheme is
between primary (primary disease of the eye with no associated conditions or
diseases) and secondary glaucomas (where the glaucoma is attributed to some
underlying condition or disorder).
Primary open-angle glaucoma is an optic neuropathy, which is  chronic
and progressive in nature. It is usually a bilateral and asymmetrical disease of
unknown cause where optic nerve is damaged by IOP and other unknown
factors leading on to loss of ganglion cells of the retina.
Idiopathic open-angle glaucoma,chronic open-angle glaucoma (COAG)
and  chronic simple glaucoma are the other  synonymous terms used in context
with primary open angle glaucoma.
Three elements are needed to make the diagnosis POAG
 (1) Anterior chamber angles must be ‘open’ by gonioscopy
(2) There must be no known secondary cause for the glaucoma
(3) There must be optic nerve damage, manifested by optic disc changes
or nerve fiber layer changes consistent with glaucoma or characteristic visual
field abnormalities.
 It is most notable that intraocular pressure is not part of the definition but
increased IOP is a risk factor associated with the development of disease and is
not the disease itself.
TERMINOLOGY
Normal-Tension Glaucoma
Normal tension glaucoma is one where patients have optic disc and visual
field changes suggestive of glaucoma but their IOP is always below 21mmHg.
Such patients with the above said findings with a open anterior chamber angle
are said to have normal tension glaucoma.
Ocular Hypertension
Patients who have an IOP consistently above 21 mm Hg for which there
is no apparent cause with normal optic nerve head and visual fields are said to
have ocular hypertension.
Glaucoma suspect
A person with at least one of the following findings in either eye is named
as Glaucoma Suspect.
? Elevated IOP over 22 mmHg.
? Glaucomatous Optic nerve head changes or nerve fiber layer defect.
? Visual field abnormality consistent with  glaucoma.
EPIDEMIOLOGY
• In 2010, it is estimated that glaucoma affects approximately 60.5 million
people worldwide.
• There were 44.7 million people with primary open-angle glaucoma of the
total predicted 60.5 million people with glaucoma.
• Glaucoma in India:
           In India 11.2 million people were affected with glaucoma, among them
POAG is estimated to affect 6.48 million persons in 2010.
PATHOPHYSIOLOGY
Two pathophysiological issues to be addressed in primary open angle
glaucoma includes:
(1) Pathophysiology of elevation of  intraocular pressure.
 (2) Pathophysiology of  cupping and atrophy of the optic nerve.
PATHOPHYSIOLOGY OF INCREASED INTRAOCULAR PRESSURE:
Elevated IOP in open angle glaucoma occurs secondary to structural
alterations  in the aqueous outflow channels. Juxtacanalicular tissue with its
greatest phagocytic activity and high mucopolysaccharide content is considered
as the main site of aqueous outflow resistance.
Mechanics of outflow obstruction have been explained by various theories .
Some of them are as follows:
1. Materials like glycosaminoglycans, amorphous material, red blood cells,
extracellular lysosomes ,pigment, protein etc  can get deposited and cause
obstruction of the trabecular meshwork.
2. A normal constituent which is synthesized excessively or not catabolized
properly can also obstruct the meshwork. Added on to it normal phagocytic
activity  is lost in this type of glaucoma trabecular meshwork to self clean
itself leading on to increased resistance.
3. Giant vacuoles found in the the inner wall of Schlemm’s canal has an
important role in maintenance of IOP and their reduction in size and number
seen in open angle glaucoma is thought to be responsible for elevated IOP.
4.  Trabecular endothelial cells are involved in functions like synthesis and
degradation of macromolecules and phagocytosis. These functions are lost
when there is loss of trabecular endothelial cells and lead on to glaucoma.
HISTOPATHOLOGY
 Histopathologic studies of the aqueous outflow pathway in patients with
primary type of open angle glaucoma has revealed abnormalities like fused
trabecular beams,fragmentation and long-spacing of collagen in the trabecular
beams, decreased number of trabecular endothelial cells, decreased number of
giant vacuoles in the inner wall of schlemn’s canal, narrowing or collapse of
schlemm’s canal, thickened scleral spur etc.
       Despite extensive research the precise mechanism of outflow obstruction
in this condition cause of the still remains unclear.
PATHOPHYSIOLOGY OF GLAUCOMATOUS OPTIC NEUROPATHY
Features characteristic of glaucomatous optic neuropathy includes:
? Characteristic cupping of the optic disc
? Apoptosis of retinal ganglion cells and their axons.
The mechanisms of glaucomatous damage and the initial site of
involvement is not well understood till date. It is thought that multiple factors
and their complex interplay lead on to glaucoma rather than each factor acting
individually .Final end result will be permanent visual loss as a result of retinal
ganglion cell death.
Various theories have been put forth to explain the pathophysiology of
ganglion cell death namely
? Backward bowing of the lamina cribrosa  cause mechanical kinking of the
axons as they exit through the lamina pores.This in turn lead to focal
ischemia, interfere with axoplasmic flow ,deprive the axons of neurotrophins
and trigger death of axons.
? Vascular theories propose that cell death is triggered by ischemia.
? Genetic theories propose that cell death is triggered by genetic
predisposition.
 Following the death of individual axons, substances may be released into
the environment that causes a secondary triggering of apoptosis in neighboring
cells, including glutamate (a neurotransmitter that may cause excitotoxicity),
calcium, nitric oxide, and free radicals.
RISK FACTORS
Risk factors involved in the occurrence of primary open angle glaucoma
can be grouped as
      Demographic factors
      Ocular factors
      Systemic factors
DEMOGRAPHIC RISK FACTORS
AGE
POAG is becomes more prevalent as age advances and is seen most often
in patients around 60 years of age (and rarely before 40 years old). Prevalence
tends to roughly double for each decade over 40 years and is about 10 fold
higher above 80 years of age.8,9,10
GENDER
 There is discordance among various studies about gender association in
glaucoma. Frammingham study62 , studies by  Ramakrishnan et al 9, Leske et al
etc have reported increased prevalence of POAG in males whereas Blue
mountain eye study , St lucia ,Andhra Pradesh eye study etc have reported
increased prevalence in females. Some studies found no significant association.
RACE
POAG is more common in people of African ancestry and the disease
tends to more severe in them.
FAMILY HISTORY
      Family history of glaucoma is associated with an increased risk of POAG.
Genetic influence occurs through polygenic or multifactorial transmission.
Recent studies have demonstrated the association of  juvenile-onset open-angle
glaucoma with GLC1A gene located on chromosome 1 in the q23–25 region
and adult-onset open-angle glaucoma with GLC1B gene located on
chromosome 2.
OCULAR RISK FACTORS
INTRAOCULAR PRESSURE
Intraocular pressure is considered to be the major and treatable risk factor
involved in the development and worsening of glaucoma. Prevalence of nerve
damage is higher among individuals who have pressures of 25-30 mm Hg.
CENTRAL CORNEAL THICKNESS
 Central corneal thickness has been shown in many recent studies, not
only to affect the accuracy of intraocular pressure measurements, but also to
perhaps act as its own intrinsic risk factor for glaucoma damage.There is
increased risk of  conversion from ocular hypertension to open-angle glaucoma
in patients with thin corneas. People of African ancestry had thinner corneas
and this is explained as the factor responsible for increased risk for conversion
from ocular hypertension to open-angle glaucoma among black population.
MYOPIA
 Many studies have associated myopia with open angle glaucoma but the
mechanisms are not fully explained, increased IOP and large  cup disc ratioseen
in myopic patients  is thought of as a risk factor.46
SYSTEMIC RISK FACTORS
DIABETES MELLITUS
The prevalence of POAG have been reported to be higher in diabetic
population in many population based studies.14,64,65
HYPERTENSION
     Hypertension may contribute to the risk of development of glaucoma
through vascular mechanisms and increased IOP occurring with increased
systemic blood pressure may also play a role.
VASOSPASM
Associations between vasospastic phenomenon (cold extremities,
migraine, Raynaud’s syndrome) and glaucoma have led to an ischaemic
hypothesis for glaucoma.
SMOKING
Blue mountain eye study reported a small increase in IOP in smokers but
other studies have reported no difference in the prevalence of POAG among
smokers and non smokers.
HYPERTENSION AND PRIMARY OPEN ANGLE GLAUCOMA
There are a number of risk factors involved in the development and
progression of primary open angle glaucoma but treatment for glaucoma till
date is targeted towards IOP reduction. But despite sufficient IOP reduction,
disease continue to progress and many patients suffer ongoing vision loss, this
explains the fact that there are risk factors other than IOP which can also cause
disease development and progression. Risk factors like advancing age, positive
family history and ethnicity (especially African ancestry) have long been
associated with glaucoma. Recently risk factors which alter the blood supply of
the optic nerve head like systemic HT, atherosclerosis and vasospasm have been
evaluated. Evaluation of the role of systemic hypertension in the development
and progression of primary open angle glaucoma has attracted attention in
recent years as it represents a potentially modifiable risk factor and thus
provides option for new treatment strategies beyond IOP reduction.
OPTIC NERVE HEAD PERFUSION
Blood flow to the optic nerve head is given by the formula
Blood flow = Ocular perfusion pressure / vascular resistance
OCULAR PERFUSION PRESSURE
Blood flow to the capillary network of the lamina cribrosa region of the
optic nerve can be described by a parameter known as ocular perfusion pressure
(OPP). Ocular perfusion pressure is given by the formula i.e
OPP = BP – IOP.
This relationship  between IOP and blood pressure is important clinically
because glaucoma and hypertension often co-exist in ageing populations.
Abnormalities in  blood flow and the  ability of the eye to maintain its blood
flow against changes in perfusion pressure are central to the pathogenesis of
glaucoma. When the capacity  of the eye to maintain blood flow in the face of
variations of OPP by a process called autoregulation decreases, the risk of
impaired oxygen and nutrients supply to the eye increases  and this in turn can
result in neuronal dysfunction.
BLOOD PRESSURE AND INTRAOCULAR PRESSURE
Many population based studies have proved an association between high
blood pressure and IOP . Each 10 mmHg rise in systolic blood pressure is
associated with but only a small increase in IOP (approximately 0.27 mmHg).
The physiological basis of this relationship between blood pressure and IOP
remains unclear.
Various hypotheses has been proposed for the same
? Both elevated IOP and blood pressure might be driven by a common
extrinsic factor such as an age-related increase in the sympathetic tone.
? elevated BP rises ciliary artery pressure  which in turn results in an
increase of  ultrafiltration component of aqueous production, resulting in
IOP elevation.
? Small increase in venous pressure occurs as arterial pressure increases,
this increase in venous pressure reduces aqueous clearance resulting in
higher IOP.
BLOOD PRESSURE AND VASCULAR RESISTANCE
Vascular resistance in a circulation is directly related to the state &
calibre of the vessels in the circulation which in turn depends on many factors
like autoregulation, vessel wall changes like arteriosclerosis etc.
 Blood pressure can influence vascular resistance by various mechanisms.
? There is increased vascular resistance in terminal arterioles all over the
body, the basic pathology in hypertension.
? Autoregulation is the inherent ability of an organ to maintain constant
blood flow despite changes in perfusion pressure. Systemic hypertension
causes endothelial cell damage/ dysfunction and abnormal release of
vasoactive substances resulting in an alteration of autoregulatory
mechanism.
? The vascular endothelial cells release various known endothelial
vasoactive agents of which nitric oxide (NO; vasodilation) and
endothelin-1 (ET-1; vasoconstriction) are perhaps the most important
factors and have opposing actions in ocular blood flow.
? Abnormalities in endothelial derived vasoactive agents particularly
reduction in production of NO can occur in hypertension
? Higher systemic concentrations of catecholamines and circulating
vasoconstrictor agents like angiotensin in arterial hypertension can have a
direct effect on ONH blood flow.
               So changes in blood flow and blood pressure play a vital role in the
development and progression of glaucoma but the mechanisms involved are not
fully understood till date.
OBJECTIVES OF THE STUDY
? To determine the prevalence of primary open angle glaucoma in
patients with systemic hypertension.
? To find the association of primary open angle glaucoma, intraocular
pressure and systemic hypertension.
MATERIALS AND METHODS
         This cross sectional case control study was conducted at Stanley medical
college from November 2012 to October 2013.Patients with documented history
of hypertension and on antihypertensive medication attending hypertensive
clinic at Stanley medical college were included in the study. Informed consent
was obtained from all patients.
Sample size – 100 hypertensive patients and 100 age-sex matched non
hypertensive controls.
INCLUSION CRITERIA
      1. Patients with documented systemic hypertension on antihypertensive
medications.
      2. Patients above 40 yrs of age
     3. Age and sex matched non hypertensive controls in the ratio of  1:1
 EXCLUSION CRITERIA
     1. Patients less than 40 yrs of age
     2. Patients with secondary glaucoma
     3. Patients with diabetes and patients with family history of glaucoma.
     4. Myopia
     5. Corneal scarring/ opacity on which gonioscopy is not helpful.
     6. Previous ocular trauma or diseases other than primary open angle
glaucoma.
METHODS
 Patients with systemic hypertension and age and sex matched controls
meeting the criteria mentioned above were included in the study after taking
informed consent. A detailed history regarding past medical illness including
hypertension, duration of hypertension, diabetes mellitus, family history of
glaucoma, myopia was taken. Details regarding antihypertensive medications
and any other medications that the patient was on were also obtained.
Patients with family history of glaucoma, diabetic patients with a history
of diabetes or on treatment for the same or with an elevated fasting blood
glucose level of >140 mgs % 61 and myopic patients with a spherical equivalent
refractive error > 1.00 diopter were excluded from the study.
Systemic Hypertension was defined by documented diagnosed case of
hypertension with a blood pressure of ?140/90 and on treatment with anti
hypertensive medications.
Primary open angle glaucoma was defined by the presence of open angles
in gonioscopy with any two of the following features;
IOP >21 mm Hg
Glaucomatous optic disc changes
Visual field changes suggestive of glaucoma.
All participants underwent detailed examination. Assessment included:
? Systemic Blood Pressure recording using mercury sphygmomanometer
with average of 3 readings at an interval of 10 min in right upper limb in
supine position
?  Visual Acuity was assessed using Snellens chart.
? Slit lamp examination to evaluate anterior segment.
? Refraction
? Gonioscopy was done with Goldmann’s single mirror goniolens and
angle was graded according to Modified Shaffer’s grading.
? IOP measured using Goldmann’s applanation tonometer.
? Visual fields assessed using octopus perimetry.
? Fundus examination by direct, indirect ophthalmoscopy followed by
+90D assessment of optic nerve head with slit lamp.
? Laboratory investigations – Fasting blood sugar levels.
OBSERVATION AND RESULTS
 A total of 100 patients with systemic hypertension and 100 age & sex
matched controls were studied. Patients were divided accordingly into two
groups,
Group 1 – with systemic hypertension,  Group 2 – without systemic
hypertension, for the purpose of determining the prevalence of primary open
angle glaucoma in the two groups and analysing the statistical significance.
The statistical analysis was performed with SPSS (statistical analysis of
social science) Version 16. Tests for statistical significance were done using
Annova test. P value of less than 0.05 was considered significant. The numbers
of glaucoma patients with hypertension were compared to the number of control
subjects with the same conditions using the Fisher’s exact test and odds ratio
calculated.
AGE DISTRIBUTION
 The study population (200) consists of patients in the age group of 40 to
80 years. In group 1, there were 22 patients in the age group of 40-49 years, 31
patients in the age group of 50-59 years, 35 patients in the age group of 60-69
years and 12 patients were above 70 years of age. In group 2, there were 23
patients in the age group of 40-49 years, 33 patients in the age group of 50-59
years, 34 patients in the age group of 60-69 years and 10 patients were above 70
years of age.
Age distribution within groups is given in table 1. The mean age of
GROUP 1 is 57.94 years and mean age of GROUP 2 is 57.55 years.
TABLE 1: AGE DISTRIBUTION OF STUDY SUBJECTS
AGE GROUPS
( in years )
GROUP 1
(with systemic
hypertension)
GROUP 2
( without systemic
hypertension)
TOTAL
40 -49 22 23 45
50 – 59 31 33 64
60 -69 35 34 69
?70 12 10 22
 TOTAL 100 100 200
FIGURE 1: AGE DISTRIBUTION OF STUDY SUBJECTS
AGE DISTRIBUTION OF PATIENTS WITH GLAUCOMA
There were 9 patients (9/100) with glaucoma in group 1 and 6 patients
(6/100) with glaucoma in group 2.Among these 15 patients with glaucoma, 5
were in the age group of 50-59 years, 7 were in the age group of 60-69 years
and 3 were above 70 years of age.
Among 15 patients with POAG – 33.3 % (5/15) were below 60 years of
age and 66.6% (10/15) were above 60 years of age. The mean age of patients
with glaucoma was 62.6 years.
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TABLE 2: AGE DISTRIBUTION OF GLAUCOMA PATIENTS
AGE
GROUPS
( in years )
GLAUCOMA PATIENTS TOTAL
GROUP 1
(with
systemic
hypertension)
GROUP 2
(without
systemic
hypertension)
40 -49 - - -
50 – 59 3 2 5
60 -69 4 3 7
?70 2 1 3
TOTAL 9 6 15
FIGURE 2: AGE DISTRIBUTION OF GLAUCOMA PATIENTS
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GENDER DISTRIBUTION
There were 44 males and 56 females in group 1 and in group 2 there were
45 males and 55 females. The study subjects (200) in total consisted of 89 males
(89/200) and 111 females (111/200) i.e. 44.5 % were males and 55.5 % were
females.
FIGURE 3: GENDER DISTRIBUTION OF STUDY SUBJECTS
GENDER
FEMALE
MALE
44.5 %
89/200 55.5%
111/200
PREVALENCE OF POAG IN DIFFERENT GENDERS
 POAG was present in 5 males and 4 females in group 1 and in 4 males
and 2 females in group 2.Among 15 (15/200) patients with POAG, 9 were
males (9/15) and 6 were females (6/15). There was no statistically significant
difference in the gender distribution of POAG patients.
P Value – 0.60.
TABLE 3: GENDER DISTRIBUTION OF POAG PATIENTS
GENDER GROUP 1
(with systemic
hypertension
GROUP 2
(without systemic
hypertension)
TOTAL
MALE 5 4 9
FEMALE 4 2 6
TOTAL 9 6 15
BLOOD PRESSURE
The mean systolic and diastolic blood pressure of the study subjects were
as follows:
         POAG PRESENT:
               HYPERTENSIVE GROUP:
                         SYSTOLIC = 143.11 mmHg
                         DIASTOLIC = 88.89 mmHg
               CONTROL GROUP:
                         SYSTOLIC = 115 mmHg
                         DIASTOLIC = 75 mmHg
FIGURE 4: BLOOD PRESSURE IN PATIENTS WITH POAG
        POAG ABSENT:
                  HYPERTENSIVE GROUP:
                          SYSTOLIC = 138.52 mmHg
                         DIASTOLIC = 88.13 mmHg
              CONTROL GROUP:
                          SYSTOLIC = 116.59 mmHg
                         DIASTOLIC = 74.57 mmHg
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FIGURE 5: BLOOD PRESSURE IN PATIENTS
WITHOUT POAG
TABLE  4:BLOOD PRESSURE AND POAG
GROUP POAG   PRESENT POAG ABSENT
SYSTOLIC
BLOOD
PRESSURE
DIASTOLIC
BLOOD
PRESSURE
SYSTOLIC
BLOOD
PRESSURE
DIASTOLIC
BLOOD
PRESSURE
HYPERTENSIVE
GROUP
143.11 88.89 138.52 88.13
CONTROL
GROUP
115 75 116.59 74.57
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DURATION OF HYPERTENSION
 Duration of hypertension of the 100 hypertensive subjects was grouped
as follows:
TABLE 5: DURATION OF HYPERTENSION
DURATION OF HYPERTENSION NO OF SUBJECTS
< 1 YEAR 20
?1 YEAR TO < 5 YEARS 34
? 5 YEARS TO < 10 YEARS 30
? 10 YEARS 16
TOTAL 100
FIGURE 6: DURATION OF HYPERTENSION
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DURATION OF HYPERTENSION AND POAG
             Among glaucoma subjects in group 1, 5 were hypertensive for ?10
years and the remaining 4 were hypertensive for less than 10 years. Duration of
hypertension of glaucoma subjects were as follows:
TABLE 6: DURATION OF HYPERTENSION AND POAG
DURATION OF
HYPERTENSION
NO OF SUBJECTS WITH
POAG
< 1 YEAR -
?1 YEAR TO < 5 YEARS 1
? 5 YEARS TO < 10 YEARS 3
? 10 YEARS 5
TOTAL   9
Out of  9 patients with glaucoma in hypertensive group,
55.5% (5/9) was hypertensive for ?10 years.
FIGURE 7: DURATION OF HYPERTENSION AND POAG
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INTRAOCULAR PRESSURE
Mean IOP in hypertensive group was 17.30 with a standard deviation of
3.268.  Mean IOP in control group was 16.02 with a standard deviation of
3.250.
TABLE 7: MEAN IOP OF STUDY SUBJECTS
GROUP MEAN IOP
P VALUE
=0.006
HYPERTENSIVE
GROUP
17.30 ± 3.268
CONTROL GROUP 16.02± 3.250
 STATISTICAL ANALYSIS
    By applying annova table, there is a statistical significant difference in
IOP between the two groups with a P value of 0.006.
GLAUCOMA AND INTRAOCULAR PRESSURE
 There were 15 definitive cases of glaucoma meeting the defined criteria
for  diagnosis  of  POAG.  Nine  of  them  had  an  IOP  above  21  mm  Hg  and
remaining six had optic disc and field changes suggestive of glaucoma but the
IOP was < 21 mm Hg.
Among 200 subjects studied, 18 people had IOP above 21 mmHg. 10 of
them had POAG & remaining 8 were ocular hypertensive without optic disc or
field changes.
TABLE 8 – IOP AND GLAUCOMA
IOP POAG PRESENT POAG ABSENT TOTAL
(%)
GROUP 1
(WITH HT)
GROUP 2
(WITHOUT
HT)
GROUP 1
(WITH
HT)
GROUP 2
(WITHOUT
HT)
> 21 5 5 5 3 18(9%)
< 21 4 1 86 91 182(91%)
TOTAL 9 6 91 94 200
        No of glaucoma patients
                             With IOP  > 21mmHg          - 10
                             With IOP  < 21 mmHg         - 5
                   Ocular hypertensives           - 8
FIGURE 8: INTRAOCULAR PRESSURE AND POAG
SYSTEMIC HYPERTENSION AND POAG
Out of 200 subjects studied, 15 of them was found to have glaucoma
amounting to an OVERALL PREVALENCE rate of   7.5%.
    % PREVALENCE IN
    HYPERTENSIVE GROUP   - 9%
    NON HYPERTENSIVE GROUP – 6%
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TABLE 9: PREVALENCE OF POAG
RISK FACTOR POAG
Present
POAG
Absent
TOTAL
HYPERTENSION + 9 91 100
HYPERTENSION - 6 94 100
TOTAL 15 185 200
STATISTICAL ANALYSIS
Odds ratio and risk estimate was found to be 1.936 with a 95%
confidence interval ranging from 0.687 to 5.457 .Odds of hypertensive patient
developing POAG was 1.936 which was not statistically significant.
FIGURE 9:HYPERTENSION AND POAG
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DISCUSSION
Glaucoma is the most common cause of irreversible blindness in the
world and according to WHO estimate, 12.3% of blindness in the world is due
to glaucoma. POAG is often asymptomatic characterised by progressive retinal
ganglion cell death and visual field loss. IOP still remains the focus of therapy
but many patients experience continued progression of disease despite adequate
control of IOP. Extensive research is underway to identify other risk factors like
vascular factors, genetics and other systemic conditions that may be responsible
for such progression. Majority of those with glaucoma remain undetected, hence
identification of risk factors will help in screening this high risk population so
that the disease can be diagnosed early which in turn can lead to a reduction in
visual morbidity associated with glaucoma.
POAG is a multifactorial disease influenced by various factors like age,
race, familial predisposition etc. Prevalence of POAG varies in different
population with Africans being affected more with higher prevalence rate (4-
8%), and the prevalence rate in white population is in the  range of 1-3%. The
estimated prevalence of POAG in India is between 0.41 % (Vellore Eye
Survey)60 and  2.56 % (Aravind Comprehensive Eye Survey)19,8 . A total of 200
patients were examined in our study, among them 15/200 had POAG, with a
prevalence rate of 7.5 %. This study being a hospital based study with some
amount of referral bias may be a contributing factor for the higher prevalence as
compared to other studies which are population based studies.
The mean age of our study population is 57.94 years in hypertensive
group and 57.55 years in nonhypertensive group. Among 15 patients with
POAG – 33.3 % (5/15) were below 60 years of age and 66.6% (10/15) were
above 60 years of age, this suggest that occurrence of POAG increases with
increasing age.The mean age of patients with glaucoma in our study was found
to be 62.6 years. Similar results were reported in other studies like Latino eye
study63 (Mean age -65.4 yrs), West Bengal eye survey57 (Mean age 61.7 yrs)
Chennai glaucoma study (mean age - 59.9 yrs) and Aravind comprehensive eye
survey9 (Mean age 60.8 yrs).
Our study comprised of 89 males and 111 females, and POAG was
diagnosed in 9 males (9/15) and 6 females (6/15) .Many studies done across the
world have reported no gender difference in the occurrence of POAG including
studies by Vijaya et al 19and Venkatraman et al from India. But some studies
like those by Ramakrishnan et al9 , Leske et al21 etc have reported increased
prevalence of POAG in males whereas Blue mountain eye study11 , Andhra
Pradesh eye study10 etc have reported increased prevalence in females. In our
study we found no statistically significant gender difference in prevalence of
POAG. [P Value - 0.358]
In our study among the patients with glaucoma in hypertensive group
55.5% were hypertensive for atleast 10 years of duration, this shows that
duration of hypertension may have an influence on the development of
glaucoma probably by the altered autoregulatory and arteriosclerotic changes
occurring in long term hypertensives.
There was statistically significant difference [P Value -0.006] in the mean
IOP of hypertensive subjects when compared to non hypertensive subjects in
our study with the IOP of hypertensive patients being higher.   Elevation of IOP
with increased blood pressure is an established factor confirmed by various
studies. 21,59.
The relationship between systemic hypertension and POAG is complex
and the information available on the association of systemic hypertension with
POAG often appears different among different population. Several large
epidemiologic studies have been done worldwide to investigate this
relationship, the results of which are conflicting. These conflicting results are
not surprising because of the racial difference that exists in the occurrence and
complications of hypertension and the complex pathophysiological mechanisms
involved in the development of primary open angle glaucoma. According to
ischemic hypothesis, systemic hypertension in the presence of elevated IOP
would be protective as it would increase the perfusion pressure but chronic
hypertensives will also have microvascular damage, increased vascular
resistance and defective autoregulation which in turn can reduce ocular
perfusion pressure increasing the risk of ischemic damage.
The Egna-Neumarkt15, Rotterdam58, and Blue Mountain Eye studies47
have reported significant associations between systemic BP and POAG in their
cross-sectional data, whereas the Barbados Eye Study21, Early Manifest
Glaucoma Trial, Latino eye study63 etc do not support any association between
systemic BP and occurrence of POAG.
In our study we found no statistically significant correlation between
occurrence of POAG and systemic hypertension. The odds of hypertensive
patients developing POAG was 1.936 with a 95% confidence interval of 0.687
to 5.457 which was not statistically significant. Our results were comparable to
Indian studies like Aravind comprehensive eye survey9 (Odds Ratio -1.0) and
Chennai glaucoma study8 (Odds ratio - 1.02) which also found no association
between hypertension and POAG. Studies by Tielsch et al 47[Black subjects:
Odds Ratio: 1.24, White subjects: Odds Ratio: 0.73] and Uhm and Shin et al48
(Odds Ratio=1.19) also found no significant relationship between HT and
POAG.
STUDY
MEASURE OF
ASSOCIATION
BETWEEN HT  & POAG
(OR- ODDS RATIO)
STATISTICAL
SIGNIFICANCE
Baltimore study - Tielsch Black subjects: OR: 1.24  Weak correlation
et al White subjects: OR: 0.73
Uhm and Shin et al OR   -1.19 Not statistically
significant
Aravind comprehensive
eye survey
OR  -1.0 Not statistically
significant
Chennai glaucoma study OR   - 1.02 Not statistically
significant
Our study OR   -1.936 Not statistically
significant
The present study has some limitations. Our study is a hospital based
study with a small sample size as compared to other related studies which are
population based studies with a large sample size. Factors such as systemic
antihypertensive drugs that the patient was on was not included in the present
analysis but are reported to be associated with the development of POAG.
CONCLUSION
Hypertension has been found to be a risk factor for open-angle glaucoma
in various studies and there are studies which contradict the same. The results of
our study did not show any significant association of systemic hypertension
with POAG. Despite the positive correlation between blood pressure and IOP,
the actual change in IOP with increasing blood pressure is small. Since it has
been established that IOP is a significant risk factor for POAG, it should be
measured and accounted for. It is also found that frequency of primary open
angle increases with increasing age and duration of hypertension.
It can be concluded that the results are insignificant to consider systemic
hypertension as an independent risk factor for glaucoma but persons with long
duration of hypertension and advancing age, need to be monitored for high IOP
and optic nerve head changes to aid in early diagnosis and also to minimize
visual morbidity and blindness due to glaucoma.
           A population based study with a large sample size, taking into
consideration the antihypertensive medication and nocturnal dips in blood
pressure caused by such medication with nocturnal blood pressure monitoring is
essential to arrive at a definitive and clear demonstration of the relationship
between systemic hypertension and glaucoma.
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DEPARTMENT OF OPHTHALMOLOGY
STANLEY MEDICAL COLLEGE
HYPERTENSION AND PRIMARY OPEN ANGLE
GLAUCOMA
PROFORMA
Name : Address :
Age :
Sex :
OP No. : Phone Number :
History :
Hypertension History :
Hypertension : Yes No
Duration :
On Treatment : Yes No
Medications
Glaucoma :
Known  Glaucoma patient :  Yes No
On Treatment : Yes No
Medications :
Other Co Morbidities :
Past  History :
Personal History :
Family History :
Examination :
Pulse Rate :
Blood  Pressure : Systolic –
Diastolic  -
Ocular Examination : Right Eye Left Eye
Vision :
Distance :
Near Vision :
Colour Vision :
 Slit  Lamp Examination :
Fundus :
Tonometry :
Gonioscopy :
Automated Perimetry  :
Other  Investigations :
Diagnosis :
                                      FUNDUS PICTURES
                                 AUTOMATED PERIMETRY PICTURES
                       AUTOMATED PERIMETRY PICTURES
                     AUTOMATED PERIMETRY PICTURES
LIST OF ABBREVIATIONS
  POAG            - Primary Open Angle Glaucoma
 HT                  - Hypertension
 IOP                 - Intraocularpressure
TM                  - Trabecularmeshwork
ON                  - Optic Nerve
ONH               - Optic Nerve Head
C/D RATIO    - Cup Disc Ratio
NRR                - Neuroretinal rim
OPP                - Ocular perfusion pressure
BP                  - Blood Pressure
WHO             - World Health Organisation
OR                 - Odds Ratio
D                    - Diopter
KEY TO MASTERCHART
M                   - Male
F                    - Female
RE                 - Right eye
LE                 - Left eye
BE                - Both eyes
HT                - Hypertension
CD               - Cup disc
NRR            - Neuroretinal rim
FBS              - Fasting Blood Sugar
mgs              -  milligrams
SL.NO                 NAME AGE SEX BLOOD PRESSURE
DURATION
 OF HYPERTENSION
TREATMENT FOR
HYPERTENSION
IOP GONIO FIELDS FUNDUS
FBS
mgs%
1 AKILA 75 F 140/90 10 YEARS
T.ATENOLOL
50mg   1-0-0
T.ENALAPRIL
 2.5 mg 2-0-2
RE -20
LE -20
BE
Grade-III
RE - NORMAL
LE - SUPERIOR
ARCUATE
DEFECT
BE -Grade-II  HT
RETINOPATHY
WITH RE - CD RATIO 0.6
LE - 0.6 ,INFERRIOR NRR
NOTCHING 120
2 Thilakavathy 45 F 130/90  4 months
T.Amlodipine
    2.5 mg  2-0-0
RE -20
LE -18
BE
Grade-III Normal Normal 110
3 Rashiya 41 F 130/90 1 1/2 Years
T.Metoprolol
   2.5 mg 0-0-1
RE -18
LE -16
BE
Grade-IV Normal Normal 100
4 Esthar 70 F 150/90 8 Years
T.Enalapril
 2.5 mg 2-0-2
T.Atenolol
RE -16
LE -14
BE
Grade-III Normal Normal 102
5 Vinayagan 65 M 130/70 14 Years
T.Enalapril
   2.5 mg 2-0-2
T.Atenolol
    50 mg 1-0-0
RE -18
LE -18
BE
Grade 0-1 Normal
CD ratio -0.6
 Bayonetting sign +
Laminar dot sign + 107
6 Chinnapan 45 M 140/90 5 Years
T.Amlodipine
    2.5 mg  2-0-0
RE -20
LE -18
BE
Grade-IV Normal Normal 88
7 Aadhilakshimi 55 F 140/80 4 Years
T.Amlodipine
    2.5 mg  2-0-0
RE -20
LE -18
BE
Grade-IV Normal Grade -I HT Retinopathy 84
8 Malliga 55 F 150/90 6 month
T.Enalapril
   2.5 mg 2-0-2
T.Amlodipine
    2.5 mg 2-0-0
RE -18
LE -16
BE
Grade-III Normal Normal 94
9 Amla 60 F 150/80 10 Years
T.Amlodipine
    2.5 mg  4-0-4
T.Enalapril
     2.5 mg 4-0-4
RE -16
LE -16
BE
Grade-IV Normal Grade -I HT Retinopathy 99
10 Swarnam 49 F 140/90 10 Years
T.Enalapril
   2.5 mg 2-0-2
T.Amlodipine
    2.5 mg  2-0-2
T.Atenolol
    50 mg 1-0-0 RE -20
LE -18
BE
Grade-III Normal Grade -I HT Retinopathy 104
11 Jayanthi 48 F 120/90 6 Months
T.Enalapril
   2.gmg 1-0-1
RE -18
LE -18
BE
Grade-IV Normal Normal 122
12 Ravi 56 M 136/90 8 Months
T.Enalapril
   2.5 mg 4-0-4
T.Amlodipine
    2.5 mg  4-0-1
T.Atenolol
    50 mg 1-0-0
RE -20
LE -20
BE
Grade-III Normal Grade-I HT Retinopathy 138
13 Malayappan 57 M 140/90 6 MonthS
T.Enalapril
   2.5 mg 2-0-2
T.Amlodipine
    2.5 mg  2-0-0
RE -20
LE -18
BE
Grade-II Normal Normal 121
14 Rose 55 F 140/90 6 Months
T.Amlodipine
    2.5 mg  2-0-0
RE -18
LE -16
BE
Grade-III Normal Normal 126
15 Ezhilarasan 60 M 140/90 1 Year
T.Atenolol
    50 mg 1-0-0
T.Enalapril
RE -16
LE -16
BE
Grade-IV Normal Grade-I HT Retinopathy 83
16 NAMADEVAN 54 M 150/90 4 YEARS
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 1-0-0
RE - 24
LE - 26
BE
Grade-III
RE- NORMAL
LE- PARACENTRAL
SCOTOMAS
RE - CD RATIO 0.6
BAYONETTING SIGN +
LE - CD RATIO 0.7
BAYONETTING SIGN +
NRR -  CONCENTRIC
THINNING +
86
17 Chandran 54 M 160/110  5MonthS
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 2-0-2 RE -20
LE -18
BE
Grade-III Normal Grade-II HT Retinopathy 108
18 Selinmary 46 F 140/90 1 Year
T.Amlodipine
    2.5 mg  2-0-0
T.Atenolol
    50 mg 1-0-0 RE -16
LE -16
BE
Grade II-III Normal Normal 106
19 Palkins 45 F 150/90  4 monthS
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   50 mg 1-0-0
RE -18
LE -14
BE
Grade IV Normal Normal 120
20 Dhakshayini 43 F 150/90 7 monthS
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -14
LE -14
BE
Grade II-III Normal Normal 120
21 Hemavathy 42 F 130/94 1 Year
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   50 mg 3-0-3
RE -18
LE -16
BE
Grade III Normal Normal 126
22 Srinivasan 47 F 140/80 6 Month
T.Atenolol
    50 mg 1-0-0
RE -20
LE -18
BE
Grade III Normal Normal 131
23 RamaKrishnan 51 F 140/90 1 Year
T.Amlodipine
    2.5 mg  2-0-0
RE -18
LE -16
BE
Grade IV Normal Grade -I HT Retinopathy 98
24 Kuppu 61 F 120/80 1 1/2 Year
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -18
LE -16
BE
Grade III Normal Grade -II HT Retinopathy 94
25 SAROJA 65 F 130/90 10 YEARS
T.Enalapril
   2.5 mg 2-0-2
RE -20
LE -18
BE
Grade III
RE - CENTROCAECAL
SCOTOMA
LE - NORMAL
BE - GRADE II HT
RETINOPATHY
BE - CD RATIO O.7
LAMINAR DOT SIGN +
BAYONETTING SIGN + 96
26 Bavan 70 M 140/90 6 Months
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 1-0-0
RE -20
LE -18
BE
Grade IV Normal Normal 112
27 KRISHNAN 61 M 140/90 6 YEARS
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 2-0-0
RE 28
LE 24
BE
Grade III
RE - PARACENTRAL
SCOTOMA
LE - NORMAL
BE - CD RATIO 0.7
LAMINAR DOT SIGN +
BAYONETTING SIGN +
PERIPAPILLARY
ATROPHY 108
28 DURGADEVI 55 F 130/90 15 YEARS
T.Amlodipine
    2.5 mg  1-0-1
RE -22
LE -22
BE
Grade IV
RE - SUPERIOR
ARCUATE
 SCOTOMA
LE - TUBULAR VISION
RE - CD RATIO 0.7
NRR - INFERIOR
NOTCHING
LE - CD RATIO 0.8
NRR - CONCENTRIC
THINNING
118
29 Mathiyalagan 53 M 140/90 7 Years
T.Enalapril
   2.5 mg 2-0-2
RE -16
LE -16
BE
Grade III Normal Normal 116
30 RamKumar 44 M 130/80 1 Year
T.Amlodipine
    2.5 mg  1-0-0
RE -18
LE -18
BE
Grade IV Normal CD Ratio o.5 84
31 Chitra 52 F 130/81 8 Years
T.Amlodipine
    2.5 mg  1-0-0
RE -16
LE -14
BE
Grade III Normal Normal 118
32 VASUMATHY 52 F 140/90 15 YEARS
T.Enalapril
   2.5 mg 1-0-1
T.Amlodipine
    2.5 mg  1-0-0 RE -30
LE - 26
BE
Grade IV
RE-DOUBLE ARCUATE
SCOTOMA
LE- SUPERIOR
ARCUATE SCOTOMA
BE - GRADE II HT
RETINOPATHY
RE- CD RATIO 0.8
NRR - CONCENTRIC
THINNING
LE -  CD RATIO 0.8
NRR - INFERIOR
NOTCHING
116
33 AbdulRahim 65 M 140/90 10 Years
T.Atenolol
    50 mg 1/2-0-0
T.Metoprolol
   2.5 mg 1-0-0 RE -18
LE -18
RE
Grade II
LE
Grade III Normal Grade-II-Retinopathy 94
34 Santhanam 67 F 130/90 6 Months
T.Amlodipine
    2.5 mg  2-0-0
RE -16
LE -16
BE
Grade IV Normal Grade-II-Retinopathy 127
35 Devamathy 48 F 130/90 6 Years
T.Enalapril
   2.5 mg 1-0-1
T.Amlodipine
    2.5 mg  2-0-0
RE -16
LE -16
BE
Grade III Normal Normal 124
36 Sasikala 54 F 140/90 6 Years
T.Amlodipine
    2.5 mg  2-0-0
RE -16
LE -14
BE
Grade IV Normal Normal 134
37 Jayakumar 47 M 140/91 6 Months
T.Enalapril
   2.5 mg 1-0-1
T.Atenolol
    50 mg 1-0-0
RE -18
LE -20
BE
Grade II Normal Normal 128
38 Ramesh babu 63 M 140/92 5  Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 2-0-2 RE -20
LE -20
BE
Grade II Normal Normal 84
39 Bhooma 59 F 140/93 10 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 2-0-2
RE -18
LE -16
BE
Grade III Normal Normal 96
40 Ramamoorthy 76 M 140/94 5 Years
T.Atenolol
    50 mg 1-0-0
T.Enalapril
   2.5 mg 2-0-2
RE -16
LE -14
BE
Grade II Normal Grade II HT Retinopathy 92
41 SujathaDevi 60 F 140/90 10 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 2-0-2
RE -16
LE -16
BE
Grade IV Normal Grade I HT Retinopathy 102
42 VijayaLakshmi 55 F 130/90 4 Years
T.Atenolol
    50 mg 1-0-0
RE -16
LE -18
BE
Grade III Normal Normal 118
43 Narayanamoorthy 64 M 130/90 3 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -14
LE -16
BE
Grade III Normal Normal 118
44 AnthonyKumar 70 F 130/80 5 Years
T.Enalapril
   2.5 mg 1-0-1
RE -12
LE -12
BE
Grade II Normal Grade II HT Retinopathy 128
45 KHADHAR BHASHA 65 M 150/80 10 YEARS
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -20
LE - 20
BE
Grade III BE - PARACENTRAL SCOTOMA
BE- GRADE II HT
RETINOPATHY
BE -CD RATIO 0.7
CONCENTRIC NRR
THINNING
BAYONETTING SIGN + 120
46 Saroja 65 F 130/90 25 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Atenolol
    50 mg 1-0-0
RE -16
LE -14
BE
Grade II Normal Grade II HT Retinopathy 130
47 Anthoniammal 70 F 140/90 10 Years Irregular Treatment
RE -15
LE -16
BE
Grade III Normal Grade II HT Retinopathy 110
48 Kumar 60 M 130/90 5 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Atenolol
    50 mg 1/2-0-1/2
RE -14
LE -14
RE
Grade I
LE
Grade -II Normal Normal 104
49 Sudamani 45 F 130/90 2 Years
T.Amlodipine
    2.5 mg  2-0-0
RE -16
LE -18
BE
Grade III Normal Normal 88
50 UmaMaheswari 48 F 120/80 1 Year
T.Atenolol
    50 mg 1-0-0
RE -14
LE -16
BE
Grade IV Normal Normal 104
51 Bakiyam 68 F 140/90 7 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
RE -12
LE -12
BE
Grade III Normal Grade II HT Retinopathy 86
52 Shamala 50 F 120/80 2 Years
T.Atenolol
    50 mg 1-0-0
RE -14
LE -14
BE
Grade IV Normal Normal 113
53 ShahulHameed 50 F 130/90 6 Months
T.Amlodipine
    2.5 mg  1-0-0
RE -16
LE -14
BE
Grade IV Normal Grade I HT Retinopathy 94
54 Dinesh 43 M 130/80 1 year
T.Atenolol
    50 mg 1-0-0
RE -18
LE -18
BE
Grade III Normal Normal 108
55 Ravi 60 M 140/80 5 Years
T.Amlodipine
    2.5 mg  2-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -18
LE -16
BE
Grade II Normal Grade I HT Retinopathy 96
56 Usman 50 M 150/80 3 month
T.Atenolol
    50 mg 1-0-0
RE -20
LE -20
BE
Grade III Normal Normal 92
57 Uthaya 65 M 140/90 6 years
T.Enalapril
   2.5 mg 1-0-1
T.Atenolol
    50 mg 1-0-0
RE -20
LE -20
BE
Grade IV Normal Grade II HT Retinopathy 108
58 Fathima 60 F 150/90 8 years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 2-0-2
RE -16
LE -16
BE
Grade II Normal Normal 112
59 JayaKumar 70 M 140/80 10 years
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 2-0-2
RE -14
LE -12
BE
Grade III Normal Grade I HT Retinopathy 106
60 Devi 42 F 120/80 2 years
T.Atenolol
    50 mg 1-0-0
RE -14
LE -14
BE
Grade II Normal Normal 120
61 Indira 54 F 140/80 6 months
T.Atenolol
    50 mg 1-0-0
RE -16
LE -16 BE Grade IV Normal Grade I HT Retinopathy 108
62 Ganesan 68 M 140/90 3 years
T.Enalapril
   2.5 mg 2-0-2
T.Amlodipine
    2.5 mg 2-0-0
RE -18
LE -18 BE Grade IV Normal Grade II HT Retinopathy 117
63 Narayanan 56 M 130/80 1 year
T.Amlodipine
    2.5 mg 2-0-0 RE -14
LE -14 BE Grade II Normal Normal 116
64 Manjula 49 F 140/90 4 Years
T.Atenolol
    50 mg 1-0-0
RE -14
LE -16 BE Grade IV Normal Normal 84
65 Selvarani 65 F 130/90 6 years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -20
LE -20  BE Grade III Normal Grade I HT Retinopathy 94
66 Mohammed Ali 68 M 130/90 3 years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -18
LE -18  BE Grade II Normal Grade II HT Retinopathy 108
67 Egavalli 46 F 130/80 3 mpnths
T.Atenolol
    50 mg 1-0-0
RE -18
LE -16  BE Grade III Normal Normal 106
68 JAMES 60 M 150/90 7 YEARS
T.Enalapril
   2.5 mg 2-0-2
RE 24
LE 22  BE Grade IV
RE - INFERIOR
ARCUATE DEFECT
LE - NORMAL
RE - CD Ratio 0.7
NRR - SUPERIOR
THINNING
LE - CD RATIO 0.6
108
69 Selvi 70 F 140/90 10 years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -20
LE -20  BE Grade II Normal Grade III HT Retinopathy 116
70 Basha 44 M 140/80 3 years
T.Atenolol
    50 mg 1-0-0
RE -18
LE -16  BE Grade III Normal Normal 127
71 Vasantha 68 F 140/90 3 years
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 2-0-2
RE -18
LE -16  BE Grade III Normal Grade II HT Retinopathy 130
72 Manimaran 64 M 140/80 2 years
T.Atenolol
    50 mg 1-0-0
T.Enalapril
   2.5 mg 1-0-1 RE -18
LE -18  BE Grade IV Normal Grade II HT Retinopathy 123
73 Kalaivani 54 F 140/90 8 Months
T.Atenolol
    50 mg 1-0-1
RE -16
LE -18  BE Grade IV Normal Normal 110
74 Amirtham 57 F 130/90 4 years
T.Enalapril
   2.5 mg 2-0-2
RE -12
LE -12  BE Grade III Normal Normal 92
75 Ramya 59 M 150/90 6 years
T.Atenolol
    50 mg 1-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -14
LE -16  BE Grade II Normal Normal 100
76 Lakshmi 48 F 140/80 5 months
T.Atenolol
    50 mg 1-0-0
RE -16
LE -18  BE Grade II Normal Normal 109
77 Natarajan 55 M 130/90 6 years
T.Amlodipine
    2.5 mg  2-0-2
RE -16
LE -16  BE Grade III Normal Normal 90
78 Jagatha 60 F 150/90 8 years
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 2-0-2
RE -18
LE -16  BE Grade III Normal Normal 88
79 Shanmugam 56 M 140/90 1 year
T.Atenolol
    50 mg 1-0-0
RE -18
LE -16  BE Grade IV Normal Normal 104
80 Meenakshi 58 F 130/90 1 year
T.Atenolol
    50 mg 1-0-0
RE -16
LE -18  BE Grade IV Normal Normal 129
81 Thangaraj 62 M 130/80 5 Years
T.Atenolol
    50 mg 1-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -18
LE -18  BE Grade IV Normal Normal 120
82 Nallamal 65 F 120/80 7 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 1-0-1 RE -20
LE -20  BE Grade III Normal Grade  I HT Retinopathy 117
83 Rajamma 52 F 140/90 2 Years
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 1-0-1
RE -20
LE -20  BE Grade III Normal Normal 96
84 Sarav 71 F 120/80 7 Years
T.Amlodipine
    2.5 mg  2-0-2
T.Enalapril
   2.5 mg 1-0-1
RE -16
LE -18  BE Grade III Normal Grade II HT Retinopathy 108
85 Thirumalai 60 M 120/80 2 Years
T.Atenolol
    50 mg 1-0-0
T.Enalapril
   2.5 mg 1-0-1
RE -14
LE -16  BE Grade II Normal Normal 134
86 KANNIAH 79 M 158/90 5 YEARS
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 0-0-1
RE - 20
LE - 20  BE Grade III
RE- INFERIOR
ARCUATE DEFECT
LE  -SUPERIOR
ARCUATE DEFECT
RE - CD RATIO 0.8
NRR - SUPERIOR
THINNING
LE - CD RATIO 0.8
NRR - INFERIOR
THINNING 116
87 Elumalai 56 M 140/90 8 Months
T.Atenolol
    50 mg 1-0-0
RE -16
LE -16  BE Grade III Normal Normal 120
88 Anbalagan 53 M 140/90 1 Year
T.Atenolol
    50 mg 1-0-0
RE -16
LE -16  BE Grade IV Normal Normal 110
89 Padmavathy 49 F 150/90 2 Years
T.Enalapril
   2.5 mg 2-0-2
RE -14
LE -16  BE Grade III Normal Grade I HT Retinopathy 120
90 Deivanagi 64 F 140/90 2 Years
T.Amlodipine
    2.5 mg  2-0-2
RE -14
LE -14  BE Grade IV Normal Normal 120
91 Thayappan 58 M 140/90 2 Years
T.Atenolol
    50 mg 1-0-0
RE -14
LE -16  BE Grade IV Normal Normal 110
92 Loganathan 75 M 150/90 3 Years
T.Atenolol
    50 mg 1-0-1
T.Enalapril
   2.5 mg 1-0-1
RE -20
LE -20  BE Grade IV Normal Grade I HT Retinopathy 108
93 Karpagam 60 F 150/90 7 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 2-0-2 RE -16
LE -16  BE Grade III Normal Grade II HT Retinopathy 121
94 Sarala 78 F 160/80 10 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 2-0-2
RE -16
LE -14  BE Grade II Normal Grade III HT Retinopathy 86
95 Mariyapushoa 63 F 140/80 4 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg -0-1
RE -18
LE -16  BE Grade III Normal Grade II HT Retinopathy 88
96 Devaraj 64 M 140/90 6 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg -0-1
RE -20
LE -20  BE Grade III Normal Normal 104
97 Nagarathinam 69 M 140/90 7 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg 0-0-1
RE -14
LE -16  BE Grade IV Normal Normal 94
98 Bavani 64 F 130/90 2 Years
T.Amlodipine
    2.5 mg  1-0-1 RE -14
LE -16  BE Grade IV Normal Normal 128
99 RadhanKrishnan 66 M 130/90 5 Years
T.Amlodipine
    2.5 mg  1-0-1
T.Enalapril
   2.5 mg -0-1
RE -14
LE -14  BE Grade II Normal Grade I HT Retinopathy 100
100 Rajammal 53 F 120/80 5 Years
T.Atenolol
    50 mg 1-0-0
RE -14
LE -12  BE Grade II Normal Normal 106
SL.NO.               NAME  AGE SEX B.P    IOP GONIO FIELDS FUNDUS FBS mgs%
1 Sathia moorthy 74 M 120/80
RE-20
LE-18 Grade III Normal Normal 120
2 Balan 43 M 110/70
RE-18
LE-16 Grade II Normal Normal 96
3 Dhanalakshmi 42 F 100/80
RE-14
LE-14 Grade III Normal Normal 110
4 Shanmuganathan 69 M 110/70
RE-14
LE-14
RE-Grade I
LE-Grade II Normal Normal 110
5 Thangamuthu 65 M 120/80
RE-16
LE-16 Grade III Normal Normal 100
6 Ambika 44 F 110/70
RE-16
LE-18 Grade II Normal Normal 90
7 Muthukumar 54 M 120/80
RE-16
LE-14 Grade III Normal Normal 98
8 Elamathi 56 F 130/80
RE-16
LE-16 Grade IV Normal Normal 96
9 Noorjahan 57 F 120/80
RE-12
LE-12 Grade II Normal Normal 108
10 Moorthy 61 M 120/80
RE-16
LE-18 Grade IV Normal Normal 116
11 Arputham 48 F 110/70
RE-14
LE-14 Grade III Normal Normal 88
12 Mariambeevi 49 F 110/80
RE-18
LE-20 Grade II Normal Normal 98
13 Abdul Kahim 57 M 110/70
RE-14
LE-14 Grade IV Normal Normal 96
14 Neelavathy 61 F 110/70
RE-16
LE-18 Grade III Normal Normal 86
15 Jeevarathnam 56 M 120/80
RE-16
LE-16 Grade IV Normal Normal 102
16 Balu 54 M 130/70
RE-18
LE-16 Grade III Normal Normal 114
17 Eagambaram 61 M 120/80
RE-16
LE-16 Grade IV Normal Normal 128
18 Maheswari 53 F 130/70
RE-12
LE-12 Grade IV Normal Normal 130
19 Chinnaponnu 47 F 120/80
RE-12
LE-12 Grade III Normal Normal 118
20 Mariyamma 45 F 110/70
RE-16
LE-16
RE-Grade II
LE-Grade III Normal Normal 136
21 Ashokan 42 M 110/70
RE-14
LE-12 Grade III Normal Normal 108
22 Mani 43 M 120/80
RE-14
LE-16 Grade IV Normal Normal 112
23 Sumathi 48 F 110/70
RE-14
LE-16 Grade III Normal Normal 116
24 Ramani 50 F 120/80
RE-18
LE-18 Grade III Normal Normal 98
25 CHELLADURAI 62 M 110/70
RE-20
LE-20 Grade III
BE  - SUPERIOR
ARCUATE
DEFECT
BE  - CD RATIO - 0.6
INFERIOR NRR
 NOTCHING +
BAYONETTING SIGN +
96
26 LOGANATHAN 65 M 110/70
RE-24
LE-22 Grade III BE -NORMAL
RE - CD RATIO - 0.6
SUPERIOR NRR NOTCHING
LE - CD RATIO O.5
BAYONETTING SIGN + 128
27 RajaManikkam 44 M 120/80
RE-18
LE-16 Grade IV Normal Normal 126
28 Munusamy 70 M 130/80
RE-20
LE-18 Grade III Normal Normal 130
29 Valli 60 F 120/80
RE-18
LE-16 Grade IV Normal Normal 116
30 YASODHA 71 F 110/70
RE -24
LE -18 Grade III
RE - SUPERIOR
ARCUATE DEFECT.
LE - GENERALISED
DEPRESSION
RE - CD RATIO - 0.6
INFERIOR NRR
 NOTCHING +
BAYONETTING SIGN +
LE - CD RATIO O.5
BAYONETTING SIGN + 110
31 Jayalatha 72 F 110/80
RE-16
LE-18 Grade III Normal Normal 99
32 Karuppaya 52 M 110/80
RE-14
LE-14 Grade III Normal Normal 108
33 Veeraragavan 45 M 120/70
RE-12
LE-12 Grade III Normal Normal 106
34 Seethama 54 F 120/70
RE-14
LE-14 Grade IV Normal Normal 116
35 Rahmathnisha 54 F 130/90
RE-16
LE-16 Grade III Normal Normal 120
36 Appavu 66 M 120/80
RE-14
LE-16 Grade III Normal Normal 122
37 Jahirhussain 68 M 110/70
RE-16
LE-18 Grade III Normal Normal 128
38 Malarvazhi 47 F 120/80
RE-14
LE-16 Grade IV Normal Normal 130
39 Radha 53 F 110/70
RE-14
LE-12 Grade III Normal Normal 104
40 Kamala 45 F 120/80
RE-16
LE-18 Grade IV Normal Normal 104
41 Eswariammal 62 F 110/70
RE-18
LE-18 Grade III Normal Normal 112
42 subramanian 56 M 110/70
RE-16
LE-14 Grade II Normal Normal 116
43 Vivekanandan 75 M 120/80
RE-16
LE-16 Grade III Normal Normal 117
44 Bharani 59 F 130/90
RE-18
LE-18 Grade III Normal Normal 180
45 Selvam 53 M 130/90
RE-14
LE-16 Grade IV Normal Normal 138
46 Dhanammal 72 F 120/90
RE-12
LE-12 Grade III Normal Normal 126
47 MOHAMMED ALI 58 M 120/80
RE -26
LE -14 Grade III BE - NORMAL
RE -CD RATIO 0.5
BAYONETTING SIGN +
LE - CD RATIO 0.4 118
48 Nagammal 67 F 110/80
RE-14
LE-16
RE -Grade I
LE - Grade II Normal Normal 120
49 Parameshwari 52 F 110/70
RE-12
LE-14 Grade II Normal Normal 117
50 Pushparaj 51 M 110/60
RE-12
LE-12 Grade III Normal Normal 132
51 Malliga 49 F 110/70
RE-14
LE-14 Grade III Normal Normal 104
52 Mercy 51 F 120/80
RE-16
LE-16 Grade II Normal Normal 118
53 Palraj 66 M 110/60
RE-14
LE-16 Grade III Normal Normal 134
54 Ramarajan 61 M 120/60
RE-12
LE-12 Grade III Normal Normal 109
55 Krishnaveni 63 F 100/60
RE-12
LE-14 Grade II Normal Normal 98
56 Parvathy 69 F 120/80
RE-14
LE-16 Grade III Normal Normal 132
57 Rashiyabegam 48 F 110/70
RE-16
LE-14 Grade IV Normal Normal 96
58 Varadharajan 45 M 120/80
RE-16
LE-18 Grade IV Normal Normal 88
59 Dhanalakshmi 53 F 110/80
RE-16
LE-18 Grade IV Normal Normal 94
60 Kalavathy 69 F 130/90
RE-16
LE-16 Grade III Normal Normal 106
61 HEMANTH 63 M 120/80
RE-30
LE -24 Grade IV
RE - SUPERIOR
ARCUATE DEFECT.
LE - PARACENTRAL
SCOTOMA.
BE -CD RATIO 0.6
NRR THINNING +
BAYONETTING SIGN +
LAMINAR DOT SIGN + 114
62 Asina 48 F 120/70
RE-16
LE-16 Grade III Normal 88
63 Dhanammal 64 F 130/70
RE-16
LE-16 Grade III Normal Normal 86
64 chinnakannu 67 M 110/70
RE-16
LE-14 Grade III Normal Normal 94
65 Vijayalakshmi 45 F 120/80
RE-16
LE-14 Grade IV Normal Normal 120
66 Marimuthu 70 M 110/70
RE-18
LE-20 Grade IV Normal Normal 122
67 Anandhraj 43 M 120/80
RE-20
LE-20 Grade III Normal Normal 108
68 Mehrunisha 69 F 110/70
RE-14
LE-16 Grade II Normal Normal 106
69 Easwaran 68 M 110/60
RE-16
LE-18 Grade III Normal Normal 120
70 Aarumugam 53 M 120/60
RE-16
LE-14 Grade III Normal Normal 88
71 Chellamal 56 F 130/70
RE-16
LE-14 Grade III Normal Normal 94
72 kantha 55 F 120/80
RE-14
LE-14 Grade IV Normal Normal 120
73 PremKumar 47 M 110/80
RE-16
LE-16 Grade IV Normal Normal 82
74 Durairaj 59 M 100/70
RE-12
LE-14 Grade III Normal Normal 89
75 Rosemary 60 F 110/60
RE-16
LE-16 Grade III Normal Normal 109
76 SivaKumar 55 M 110/70
RE-14
LE-12 Grade III Normal Normal 118
77 Shanthi 57 F 120/80
RE-16
LE-16 Grade II Normal Normal 114
78 Ramanan 56 M 130/80
RE-16
LE-14 Grade IV Normal Normal 86
79 Sameerabegum 53 F 140/80
RE-20
LE-18 Grade III Normal Normal 94
80 Lakshmi 63 F 130/70
RE-18
LE-18 Grade II Normal Normal 92
81 Neelavathy 64 F 120/80
RE-18
LE-18 Grade III Normal Normal 132
82 Jeevarathnam 70 M 110/70
RE-20
LE-20 Grade III Normal Normal 138
83 MOHANAMBAL 57 F 120/80
RE -26
LE -20 Grade III
RE - INFERIOR
ARCUATE
 DEFECT
LE - NORMAL
RE -CD RATIO 0.6.NRR-
SUPERIORNOTCHING.
LE - CD RATIO 0.5 121
84 Malathi 68 F 110/70
RE-14
LE-14 Grade II Normal Normal 127
85 Abdul Rahim 54 M 120/70
RE-14
LE-16 Grade II Normal Normal 83
86 UmaDevi 47 F 120/80
RE-12
LE-14 Grade II Normal Normal 94
87 Palaniammal 63 F 110/80
RE-14
LE-16 Grade III Normal Normal 89
88 Singaram 57 M 100/60
RE-16
LE-14 Grade III Normal Normal 136
89 Shanthamani 74 F 120/80
RE-20
LE-20 Grade III Normal Normal 118
90 Muhunthan 51 M 110/70
RE-16
LE-16 Grade II Normal Normal 94
91 Gandhimathi 77 F 120/80
RE-16
LE-18 Grade III Normal Normal 98
92 Subhaiah 62 M 110/70
RE-14
LE-14 Grade IV Normal Normal 108
93 Renugamhal 63 F 120/60
RE-12
LE-12 Grade III Normal Normal 102
94 Sorooharani 67 F 100/60
RE-14
LE-14 Grade II Normal Normal 88
95 Ayyappan 62 M 110/80
RE-12
LE-14 Grade IV Normal Normal 94
96 Gowri 47 F 120/80
RE-14
LE-14 Grade IV Normal Normal 96
97 NahishaBanu 65 F 130/70
RE-18
LE-18 Grade III Normal Normal 121
98 Manikkam 52 M 120/80
RE-20
LE-18 Grade II Normal Normal 128
99 Kalaivani 63 F 120/80
RE-18
LE-16 Grade III Normal Normal 120
100 Usharani 62 F 110/70
RE-16
LE-14 Grade IV Normal Normal 98
